PMDD
What is PMDD?
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder linked to the menstrual cycle. It causes intense emotional and physical symptoms during the luteal phase (the two weeks before a period), which resolve within a few days of menstruation starting.
PMDD goes far beyond typical premenstrual symptoms. It can cause severe depression, anxiety, irritability, mood swings, difficulty concentrating, fatigue, and changes in sleep and appetite. For some women, symptoms are severe enough to significantly impair work, relationships, and daily functioning for up to two weeks of every month.
PMDD affects approximately 5-8% of menstruating women in the general population.
PMDD is not PMS
PMDD is a recognised clinical condition, not an extreme version of premenstrual syndrome. It involves a heightened sensitivity to the normal hormonal fluctuations of the menstrual cycle, and it causes clinically significant distress and impairment.
PMDD and neurodivergence
ADHD and PMDD
The overlap between ADHD and PMDD is striking. Research shows that women with ADHD have a 3.19-fold higher risk of experiencing PMDD compared to women without ADHD. In one study, 31.4% of women with ADHD met criteria for provisional PMDD, compared to 9.8% of women without ADHD. Other estimates suggest that up to 46% of women with ADHD may be affected.1
This is not a coincidence. The neurochemical systems involved in ADHD and PMDD overlap significantly.
The oestrogen-dopamine connection
Both ADHD and PMDD involve dysregulation of dopamine and serotonin. The link between them runs through oestrogen, which directly modulates dopamine pathways in the brain.
During the luteal phase, oestrogen levels drop. For most women, this hormonal shift has a modest effect on mood and energy. But for women with ADHD - who already have dopamine dysregulation - the oestrogen drop can significantly worsen core ADHD symptoms. Concentration, emotional regulation, motivation, and impulse control can all deteriorate in the days before a period.
This means that many women with ADHD experience a cyclical pattern: their ADHD symptoms fluctuate with their menstrual cycle, becoming noticeably worse in the luteal phase. Some women describe this as feeling like a “different person” at different points in their cycle.
The numbers are significant
A large cross-sectional study found that women meeting ADHD screening criteria had a 4.17-fold higher risk of PMDD. The risk increased further when anxiety or depression were also present, suggesting that PMDD may be part of a broader pattern of hormonal sensitivity in neurodivergent women.1
Autism and PMDD
Research on PMDD and autism is still limited, but early findings suggest very high rates - with some estimates suggesting that up to 92% of autistic women experience PMDD symptoms, though this figure should be interpreted cautiously as studies vary in methodology.
For autistic women, the luteal phase may also exacerbate sensory sensitivities and reduce the capacity for masking and social demands. Some autistic women report that their sensory thresholds change across their cycle, with stimuli that are manageable at other times becoming overwhelming in the days before a period.
What this means in practice
For neurodivergent women, PMDD creates a pattern where symptoms are not just emotional but cognitive. The luteal phase can bring:
- worsened executive function (difficulty planning, organising, starting tasks)
- reduced working memory
- greater emotional reactivity and difficulty with emotional regulation
- increased sensory sensitivity
- lower capacity for masking and social performance
- heightened rejection sensitivity
These symptoms overlap so heavily with ADHD itself that many women do not realise their difficulties are cyclical. They may attribute the worsening to stress, personal failure, or a general decline in their mental health - when the real driver is hormonal.
You are not imagining it
If your ADHD symptoms seem to get worse before your period, you are not making it up and you are not being dramatic. The hormonal-neurochemical interaction is real, measurable, and increasingly well documented. Tracking your symptoms alongside your cycle can help you see the pattern - and can help your clinician understand what is happening.
Diagnosis
PMDD is diagnosed based on a prospective symptom diary - tracking symptoms daily for at least two menstrual cycles to confirm that symptoms occur in the luteal phase and resolve after menstruation.
For neurodivergent women, diagnosis can be complicated by the fact that ADHD symptoms fluctuate for many reasons (sleep, stress, medication timing). Careful cycle tracking that includes both ADHD symptoms and mood symptoms can help distinguish PMDD from baseline ADHD variability.
It is also important to distinguish PMDD from chronic depression or anxiety. In PMDD, symptoms are cyclical - there is a clear pattern of worsening in the luteal phase and improvement after the period starts. In depression, symptoms are more consistent across the cycle.
Treatment
Cycle tracking and planning
The first step for many neurodivergent women is simply understanding the pattern. Tracking symptoms alongside the menstrual cycle - even for two or three months - can reveal a clear cyclical pattern that helps make sense of what previously felt unpredictable.
Once the pattern is identified, cycle-synced planning can help: reducing cognitive demands during the luteal phase where possible, scheduling important tasks for the follicular phase (after menstruation, when oestrogen is rising), and building in additional support during the most difficult days.
Medication
SSRIs are the first-line treatment for PMDD. They can be taken continuously or only during the luteal phase (luteal-phase dosing). SSRIs work differently in PMDD than in depression - they take effect more quickly, often within days rather than weeks.
Combined oral contraceptives can suppress ovulation and stabilise hormone levels, reducing the cyclical hormonal fluctuations that trigger PMDD.
ADHD medication adjustment - some women benefit from an increased stimulant dose during the luteal phase, when their baseline dopamine function is further reduced by falling oestrogen. This requires careful discussion with a prescriber experienced in both ADHD and hormonal health.
Therapy
CBT and ACT can both help with managing the emotional and cognitive symptoms of PMDD, particularly the frustration and self-criticism that often accompany cyclical symptom worsening. Understanding the hormonal basis of symptoms can itself be therapeutic - it reframes the experience from personal failure to a physiological process.
Lifestyle approaches
Some women find benefit from nutritional support (magnesium, vitamin B6, calcium), regular exercise, and sleep optimisation during the luteal phase. These are not substitutes for medical treatment in severe PMDD, but they can be helpful alongside other approaches.
Getting support
PMDD is treated by GPs, gynaecologists, and psychiatrists. If you have both ADHD and PMDD, it is worth seeking a clinician who understands both conditions and can coordinate treatment.
In the UK, the following organisations provide information and support:
- NAPS (National Association for Premenstrual Syndromes) - provides information and support for PMDD
- Vicious Cycle - a UK charity specifically for people with PMDD
- Your GP - can prescribe SSRIs and refer to gynaecology or psychiatry
Ask about your hormones
If you have ADHD and notice that your symptoms get worse before your period, raise this with your ADHD clinician or GP. Many clinicians do not routinely ask about menstrual cycle effects on ADHD, but this information is important for getting the right treatment.
Further reading on neurobetter
neurobetter services
- Local services directory - find mental health services near you
- Ask a Counsellor - get a confidential response from a registered counsellor
If you are in crisis
If you are struggling right now, please visit our Get Help Now page for immediate support options, including Samaritans (116 123), Crisis Text Line (text SHOUT to 85258), and NHS 111.
-
Singh, M., Parvez, F., Chen, Y. and Wimbish, T. (2024). Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. British Journal of Psychiatry. https://doi.org/10.1192/bjp.2024.196 ↩
This page has had one contribution from our team and community, and was last updated on 17 February 2026. Keeping this content up-to-date is a difficult task, especially as details can change quickly. We welcome feedback on any of the content in the Advice Hub, including any lived experience you can share. Please login or create an account to submit feedback.
neurobetter's content and services are intended to provide information, peer support, and connections to services. They are not intended to replace, override, or contradict medical or psychological advice provided by a doctor, psychologist or other healthcare professional.